wegovy weight loss fda - Search News

Drug compounders sue FDA over semaglutide status

The Hill on MSN · 16h

Drug compounders sue over weight loss drugs’ removal from FDA shortage list

A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug

Reuters on MSN · 1d

Drug compounders sue US FDA over removal of Wegovy, Ozempic from shortage list

Drug compounders sued the U.S. Food and Drug Administration on Monday over its decision last week to remove Novo Nordisk's weight-loss and diabetes treatments Wegovy and Ozempic from its shortage list,

CBS News on MSN · 3d

FDA declares end to Wegovy and Ozempic shortage

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

ConsumerAffairs18h

Hims & Hers withdraws from Wegovy, Ozempic market

Hims & Hers is stopping its sales of an alternative to blockbuster weight-loss drugs Wegovy and Ozempic. That follows the U.S ...

1don MSN

Hims is officially phasing out its copycat weight-loss drugs, and the company's stock tumbled — again

After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results